Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation

Circulation. 2025 Jan 21;151(3):e30. doi: 10.1161/CIR.0000000000001302. Epub 2025 Jan 21.
No abstract available

Publication types

  • Published Erratum